Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1985 Dec 1;133(11):1117–1118.

Ketoconazole

Infectious Diseases and Immunization Committee
PMCID: PMC1346366  PMID: 4063919

Full text

PDF
1117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brass C., Galgiani J. N., Blaschke T. F., Defelice R., O'Reilly R. A., Stevens D. A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 Jan;21(1):151–158. doi: 10.1128/aac.21.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Craven P. C., Graybill J. R., Jorgensen J. H., Dismukes W. E., Levine B. E. High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med. 1983 Feb;98(2):160–167. doi: 10.7326/0003-4819-98-2-160. [DOI] [PubMed] [Google Scholar]
  3. DeFelice R., Johnson D. G., Galgiani J. N. Gynecomastia with ketoconazole. Antimicrob Agents Chemother. 1981 Jun;19(6):1073–1074. doi: 10.1128/aac.19.6.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Engelhard D., Stutman H. R., Marks M. I. Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med. 1984 Dec 27;311(26):1681–1683. doi: 10.1056/NEJM198412273112606. [DOI] [PubMed] [Google Scholar]
  5. Ginsburg C. M., McCracken G. H., Jr, Olsen K. Pharmacology of ketoconazole suspension in infants and children. Antimicrob Agents Chemother. 1983 May;23(5):787–789. doi: 10.1128/aac.23.5.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Heel R. C., Brogden R. N., Carmine A., Morley P. A., Speight T. M., Avery G. S. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs. 1982 Jan-Feb;23(1-2):1–36. doi: 10.2165/00003495-198223010-00001. [DOI] [PubMed] [Google Scholar]
  7. Horsburgh C. R., Jr, Kirkpatrick C. H. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med. 1983 Jan 24;74(1B):23–29. doi: 10.1016/0002-9343(83)90511-9. [DOI] [PubMed] [Google Scholar]
  8. Hughes W. T., Bartley D. L., Patterson G. G., Tufenkeji H. Ketoconazole and candidiasis: a controlled study. J Infect Dis. 1983 Jun;147(6):1060–1063. doi: 10.1093/infdis/147.6.1060. [DOI] [PubMed] [Google Scholar]
  9. Lewis J. H., Zimmerman H. J., Benson G. D., Ishak K. G. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology. 1984 Mar;86(3):503–513. [PubMed] [Google Scholar]
  10. Loose D. S., Kan P. B., Hirst M. A., Marcus R. A., Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983 May;71(5):1495–1499. doi: 10.1172/JCI110903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Maksymiuk A. W., Levine H. B., Bodey G. P. Pharmacokinetics of ketoconazole in patients with neoplastic diseases. Antimicrob Agents Chemother. 1982 Jul;22(1):43–46. doi: 10.1128/aac.22.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schürmeyer T., Nieschlag E. Ketoconazole-induced drop in serum and saliva testosterone. Lancet. 1982 Nov 13;2(8307):1098–1098. doi: 10.1016/s0140-6736(82)90021-6. [DOI] [PubMed] [Google Scholar]
  13. Van Der Meer J. W., Keuning J. J., Scheijgrond H. W., Heykants J., Van Cutsem J., Brugmans J. The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother. 1980 Jul;6(4):552–554. doi: 10.1093/jac/6.4.552. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES